• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical Utility of Home versus Hospital Spirometry in Fibrotic Interstitial Lung Disease: Evaluation after INJUSTIS Interim Analysis.

作者信息

Khan Fasihul, Howard Lucy, Hearson Glenn, Edwards Colin, Barber Chris, Jones Steve, Wilson Andrew M, Maher Toby M, Saini Gauri, Stewart Iain, Jenkins Gisli

机构信息

Department of Respiratory Medicine, University of Nottingham Nottingham, United Kingdom.

patientMpower Ltd. Dublin, Ireland.

出版信息

Ann Am Thorac Soc. 2022 Mar;19(3):506-509. doi: 10.1513/AnnalsATS.202105-612RL.

DOI:10.1513/AnnalsATS.202105-612RL
PMID:34534053
Abstract
摘要

相似文献

1
Clinical Utility of Home versus Hospital Spirometry in Fibrotic Interstitial Lung Disease: Evaluation after INJUSTIS Interim Analysis.家庭肺量计与医院肺量计在纤维化间质性肺疾病中的临床效用：INJUSTIS中期分析后的评估
Ann Am Thorac Soc. 2022 Mar;19(3):506-509. doi: 10.1513/AnnalsATS.202105-612RL.
2
Variability of forced vital capacity in progressive interstitial lung disease: a prospective observational study.进展性间质性肺疾病用力肺活量的可变性：一项前瞻性观察研究。
Respir Res. 2020 Oct 19;21(1):270. doi: 10.1186/s12931-020-01524-8.
3
The Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS): description of the protocol for a multicentre prospective observational cohort study identifying biomarkers of progressive fibrotic lung disease.并非特发性肺纤维化研究（INJUSTIS）：一项多中心前瞻性观察队列研究方案的描述，旨在确定进行性肺纤维化疾病的生物标志物。
BMJ Open Respir Res. 2019 Jun 4;6(1):e000439. doi: 10.1136/bmjresp-2019-000439. eCollection 2019.
4
Disease Behaviour During the Peri-Diagnostic Period in Patients with Suspected Interstitial Lung Disease: The STARLINER Study.疑似间质性肺病患者诊断前期间的疾病行为：STARLINER 研究。
Adv Ther. 2021 Jul;38(7):4040-4056. doi: 10.1007/s12325-021-01790-y. Epub 2021 Jun 11.
5
Value of spirometry in detecting volume restriction in interstitial lung disease patients. Spirometry in interstitial lung diseases.肺量计在检测间质性肺疾病患者容量限制中的价值。间质性肺疾病中的肺量计。
Respiration. 2004 Jul-Aug;71(4):374-9. doi: 10.1159/000079642.
6
Feasibility of online home spirometry in systemic sclerosis-associated interstitial lung disease: a pilot study.系统性硬化症相关间质性肺疾病在线家庭肺量计检查的可行性：一项试点研究。
Rheumatology (Oxford). 2021 May 14;60(5):2467-2471. doi: 10.1093/rheumatology/keaa607.
7
["Mixed" changes in spirometry--what is it about?].肺量计检查中的“混合性”变化——是怎么回事？
Pneumonol Alergol Pol. 2003;71(11-12):485-7.
8
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.吡非尼酮治疗无法分类的进行性纤维化间质性肺疾病患者：一项双盲、随机、安慰剂对照、2 期临床试验。
Lancet Respir Med. 2020 Feb;8(2):147-157. doi: 10.1016/S2213-2600(19)30341-8. Epub 2019 Sep 29.
9
Functional respiratory assessment in interstitial lung disease.间质性肺疾病的功能性呼吸评估
Rev Invest Clin. 2015 Jan-Feb;67(1):5-14.
10
Diagnosis and Management of Fibrotic Interstitial Lung Diseases.纤维化间质性肺疾病的诊断与管理。
Clin Chest Med. 2021 Jun;42(2):321-335. doi: 10.1016/j.ccm.2021.03.008.

引用本文的文献

1
Patient and healthcare professional perspectives on telehealth in the care of interstitial lung disease.患者与医疗保健专业人员对间质性肺疾病护理中远程医疗的看法。
Chron Respir Dis. 2025 Jan-Dec;22:14799731251366945. doi: 10.1177/14799731251366945. Epub 2025 Aug 17.
2
Innovation in Home Spirometry, as a New Out-of-Hospital Circuit in Patients: More Reality, Less Fiction.家庭肺量计的创新：作为患者院外的新途径，现实多而虚幻少
Open Respir Arch. 2025 May 13;6(Suppl 2):100441. doi: 10.1016/j.opresp.2025.100441. eCollection 2024 Oct.
3
Home Monitoring in Interstitial Lung Disease: Protocol for a Real-World Observational Study.
间质性肺疾病的家庭监测：一项真实世界观察性研究的方案
JMIR Res Protoc. 2025 Jun 12;14:e65339. doi: 10.2196/65339.
4
Viability of a new home program of forced spirometry with bronchodilator response measurement in the assessment of patients with asthma.一项新的家庭强制肺活量测定及支气管扩张剂反应测量方案在哮喘患者评估中的可行性。
Multidiscip Respir Med. 2025 Jun 4;20(1):1024. doi: 10.5826/mrm.2025.1024.
5
The role of digital health in respiratory diseases management: a narrative review of recent literature.数字健康在呼吸系统疾病管理中的作用：近期文献综述
Front Med (Lausanne). 2025 Feb 26;12:1361667. doi: 10.3389/fmed.2025.1361667. eCollection 2025.
6
Assessment of Home-based Monitoring in Adults with Chronic Lung Disease: An Official American Thoracic Society Research Statement.成人慢性肺病家庭监测评估：美国胸科学会官方研究声明
Am J Respir Crit Care Med. 2025 Feb;211(2):174-193. doi: 10.1164/rccm.202410-2080ST.
7
Feasibility and acceptability of remotely monitoring spirometry and pulse oximetry as part of interstitial lung disease clinical care: a single arm observational study.远程监测肺量计和脉搏血氧饱和度作为间质性肺疾病临床护理一部分的可行性和可接受性：一项单臂观察性研究。
Respir Res. 2024 Apr 15;25(1):162. doi: 10.1186/s12931-024-02787-1.
8
REMOTE-ILD study: Description of the protocol for a multicentre, 12-month randomised controlled trial to assess the clinical and cost-effectiveness of remote monitoring of spirometry and pulse oximetry in patients with interstitial lung disease.远程ILD 研究：一项多中心、12 个月随机对照试验的方案描述，旨在评估远程监测间质性肺疾病患者的肺量计和脉搏血氧饱和度的临床和成本效益。
BMJ Open Respir Res. 2024 Feb 28;11(1):e002067. doi: 10.1136/bmjresp-2023-002067.
9
Assessing the acceptability and feasibility of remote spirometric monitoring for rural patients with interstitial lung disease: a multimethod approach.评估远程肺量计监测对农村间质性肺疾病患者的可接受性和可行性：一种多方法研究。
Respir Res. 2024 Feb 20;25(1):92. doi: 10.1186/s12931-024-02735-z.
10
Evaluating a Remote Monitoring Program for Respiratory Diseases: Prospective Observational Study.评估呼吸系统疾病远程监测项目：前瞻性观察研究。
JMIR Form Res. 2023 Nov 24;7:e51507. doi: 10.2196/51507.